China Rett Syndrome Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Rett syndrome is a rare genetic neurological disorder that affects the brain development causing development disorders, loss of motor skills and speech, and it exclusively affects females. Only in rare cases are males affected. Globally classic Rett syndrome is the most common form of the disease, seen in 80-85 percent of all cases, with symptoms usually appearing between ages 6-18 months. The global incidence of Rett is estimated to be 1 in 10,000 female births.
China is a growing market for Rett syndrome due to factors such as increase in incidence rate (1 in 10,000 female births across the globe). In addition to this the other factors that contribute to the growth of market are rise in healthcare expenditure, increase in awareness and rise in female population and increase in genetic mutations.
However, there are some restraining factors for the growth of Rett syndrome therapeutics market in China such as undiagnosed or misdiagnosed cases and determining the true frequency of these conditions in the general population is difficult.